Detalhe da pesquisa
1.
Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination.
Haematologica
; 108(1): 250-256, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36106394